Prognostic and predictive implications of HER2/ERBB2/neu gene mutations in lung cancers-Reference-Cited by-同舟云学术

Prognostic and predictive implications of HER2/ERBB2/neu gene mutations in lung cancers

Published:2011-10 Issue:1 Volume:74 Page:139-144
ISSN:0169-5002
Container-title:Lung Cancer
language:en
Short-container-title:Lung Cancer

Author:

Tomizawa Kenji,Suda Kenichi,Onozato Ryoichi,Kosaka Takayuki,Endoh Hideki,Sekido Yoshitaka,Shigematsu Hisayuki,Kuwano Hiroyuki,Yatabe Yasushi,Mitsudomi Tetsuya

Publisher

Elsevier BV

Subject

Cancer Research,Pulmonary and Respiratory Medicine,Oncology

Reference31 articles.

1. Target-based agents against ErbB receptors and their ligands: a novel approach to cancer treatment;Normanno;Endocr Relat Cancer,2003

2. Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer;Slamon;Science,1989

3. HER-2/Neu alterations in non-small cell lung cancer: a comprehensive evaluation by real time reverse transcription-PCR, fluorescence in situ hybridization, and immunohistochemistry;Pellegrini;Clin Cancer Res,2003

4. Trastuzumab in the treatment of advanced non-small-cell lung cancer: is there a role? Focus on eastern cooperative oncology group study 2598;Langer;J Clin Oncol,2004

5. Evaluation of HER-2/neu gene amplification and protein expression in non-small cell lung carcinomas;Hirsch;Br J Cancer,2002

Cited by 128 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Quantitative Measurement of HER2 Expression in Non–Small Cell Lung Cancer With a High-Sensitivity Assay;Modern Pathology;2024-09

2. The Genetic Analysis and Clinical Therapy in Lung Cancer: Current Advances and Future Directions;Cancers;2024-08-19

3. Prevalence and treatment of human epidermal growth factor receptor 2-altered non-small cell lung cancer: a retrospective analysis and systematic literature review;ecancermedicalscience;2024-08-01

4. Physiologically driven nanodrug delivery system for targeted lung cancer treatment;Exploration of Medicine;2024-04-25

5. Mechanisms of resistance to targeted therapy and immunotherapy in non-small cell lung cancer: promising strategies to overcoming challenges;Frontiers in Immunology;2024-04-09